A detailed history of Mariner, LLC transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Mariner, LLC holds 8,973 shares of SWTX stock, worth $444,612. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,973
Previous 9,123 1.64%
Holding current value
$444,612
Previous $292,000 10.96%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

SELL
$28.61 - $42.55 $4,291 - $6,382
-150 Reduced 1.64%
8,973 $324,000
Q3 2024

Nov 13, 2024

SELL
$32.04 - $42.76 $1,217 - $1,624
-38 Reduced 0.41%
9,123 $292,000
Q2 2024

Aug 13, 2024

BUY
$36.06 - $47.62 $88,383 - $116,716
2,451 Added 36.53%
9,161 $345,000
Q1 2024

May 15, 2024

BUY
$36.5 - $52.5 $24,710 - $35,542
677 Added 11.22%
6,710 $330,000
Q4 2023

Feb 14, 2024

BUY
$18.94 - $37.24 $114,265 - $224,668
6,033 New
6,033 $220,000

Others Institutions Holding SWTX

About SpringWorks Therapeutics, Inc.


  • Ticker SWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,401,100
  • Market Cap $3.09B
  • Description
  • SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...
More about SWTX
Track This Portfolio

Track Mariner, LLC Portfolio

Follow Mariner, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mariner, LLC with notifications on news.